Skip to search.
 FTSE 100 Down 0.58%

Abaxis, Inc. (ABAX)

-NasdaqGS
64.20 Down 0.03(0.05%) 19:06 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:64.23
Open:64.18
Bid:64.16 x 100
Ask:64.24 x 200
1y Target Est:64.50
Beta:0.03
Earnings Date:22 Apr - 27 Apr (Est.)
Day's Range:63.32 - 64.78
52wk Range:36.77 - 66.05
Volume:43,549
Avg Vol (3m):201,485
Market Cap:1.45b
P/E (ttm):73.79
EPS (ttm):0.87
Div & Yield:0.40 (0.60%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABAX at this time.

Comparison

Symbol% ChgMkt Cap
ABAXDown 0.05%1.45b
ALRUp 3.47%4.08b
HSKAUp 2.64%152.99m
IDXXUp 1.82%7.20b

Key Statistics

Forward P/E (1 yr):50.94
P/S (ttm):7.13
Ex-Dividend Date:27-Feb-15

Analysts

Annual EPS Est (Mar-15) :0.97
Quarterly EPS Est (Mar-15) :0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback